Once president of group research at Roche Holdings, Knowles now joins the board at Adaptimmune as a non-executive director.
He joins the firm's current chief operating officer Helen Tayton-Martin, who will become executive director.
Our weekly round-up of the bright young things and big cheeses in pharmaceuticals.
The latest changes at Bayer, biopharma, and the winner of Professional Woman of the Year in this...
This week's pharmaceutical changes begin with the election of Reuters' head to the Board of Pfizer.